Novartis pauses autoimmune cell therapy studies after deaths

Novartis halted eight clinical trials of an experimental therapy targeting autoimmune and neurological disorders in late ...
European Medical Journal

Novartis halts eight CAR-T cell therapy trials after deaths

Novartis has halted eight rap-cell clinical trials after three patients died following severe immune reactions linked to the CAR-T therapy.
RTTNews

Novartis Halts Trials For Rap-cel Immunotherapy Following Deaths From Severe Immune Reaction

Novartis AG (NOVN.S), a pharmaceutical company, has reportedly paused eight clinical trials evaluating rap-cel, a CD19 CAR-T cell therapy, following the deaths of three patients enrolled in the ...